Agilent Technologies Inc. (NYSE: A) today announced that the , part of Universite Libre de Bruxelles (ULB), has chosen the  to manage its scientific data. "The IMI subjected competitive systems to rigorous evaluation, and we're very delighted that their scientists doing the testing unanimously selected the Agilent ELN," said Debra Toburen, Agilent senior product manager, Informatics. "The Agilent ELN provides the perfect set of tools for organizing the large amounts of data generated by our scientists," said Dominique Demonté, deputy director of the IMI. "It also will be helpful in the application of our internal intellectual property policy. We based our purchase decision largely on the Agilent system's ease-of-use, architecture and also on the level of support provided by the Agilent team." The Agilent ELN is designed to provide benefits beyond eliminating paperwork. Its scalable, integrated platform simplifies and accelerates the R&D process by facilitating collaboration in a secure framework. Researchers can easily search, retrieve and share data using the ELN's Web interface.

About The IMI

Located on the BIOPARK Charleroi Brussels South, the IMI is part of the Faculty of Medicine of the ULB. Work focuses on translating discoveries "from bench to bedside" based on multidisciplinary teams of medical doctors and basic scientists. Projects are organized along four research programs addressing key questions in medical immunology: vaccine adjuvants, the immune system in early life, transplantation medicine, and immune biomarkers. Through its participation in several research networks, it is expected to contribute to the development of Wallonia in the context of the European Research Area.